The slowing of tumor growth and incomplete block of perfusion by AVA of the human U87 xenografts can be understood as remaining VEGF-independent angiogenesis signaling along with increased tissue hypoxia, which emerged in AVA-treated glioblastoma mouse xenografts [49]. This evidence concerns the gene VEGFA and neoplasm.